IRIS
NORIS, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.171
EU - Europa 3.604
AS - Asia 2.498
SA - Sud America 102
OC - Oceania 18
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 10.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.128
CN - Cina 2.046
IE - Irlanda 961
UA - Ucraina 474
FI - Finlandia 471
DE - Germania 402
RU - Federazione Russa 371
IT - Italia 331
SG - Singapore 306
SE - Svezia 292
GB - Regno Unito 127
BR - Brasile 87
FR - Francia 67
HK - Hong Kong 65
CA - Canada 38
IN - India 24
BE - Belgio 18
AU - Australia 17
RO - Romania 16
CZ - Repubblica Ceca 13
NL - Olanda 13
TR - Turchia 13
AR - Argentina 10
EU - Europa 9
IR - Iran 9
AT - Austria 8
GR - Grecia 8
CH - Svizzera 7
MU - Mauritius 5
UZ - Uzbekistan 5
KG - Kirghizistan 4
BD - Bangladesh 3
JP - Giappone 3
LU - Lussemburgo 3
PK - Pakistan 3
PT - Portogallo 3
AZ - Azerbaigian 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
HU - Ungheria 2
IQ - Iraq 2
LT - Lituania 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TM - Turkmenistan 2
VN - Vietnam 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.416
Salva come PNG Salva come JPEG
Città #
Dublin 961
Chandler 873
Jacksonville 661
Nanjing 614
Ashburn 293
Boardman 279
Nanchang 224
Princeton 194
Shenyang 184
Wilmington 181
Lawrence 180
Medford 177
Hebei 165
Changsha 164
Beijing 160
Helsinki 149
Singapore 137
Jiaxing 128
Munich 106
Tianjin 90
Ann Arbor 89
Hangzhou 88
Milan 78
Hong Kong 65
Pavia 58
Shanghai 58
Moscow 55
Woodbridge 47
New York 41
Houston 39
Los Angeles 32
Verona 32
Fairfield 28
The Dalles 28
Toronto 27
Norwalk 25
Guangzhou 23
Pune 19
Seattle 18
Brussels 17
Falkenstein 16
Des Moines 14
Jinan 14
Zhengzhou 13
Brno 12
Falls Church 12
Timisoara 12
Auburn Hills 11
Rome 10
Ankara 9
Nuremberg 9
Pescara 9
Sydney 9
Ningbo 8
Palermo 8
Paris 8
Taizhou 8
Council Bluffs 7
Kunming 7
Tappahannock 7
Turku 7
Andover 6
Frankfurt am Main 6
San Francisco 6
São Paulo 6
Belo Horizonte 5
Chongqing 5
Florence 5
Fuzhou 5
London 5
Orange 5
Ottawa 5
Tashkent 5
Turin 5
Washington 5
Bishkek 4
Brasília 4
Chicago 4
Dearborn 4
Leawood 4
Melbourne 4
Monmouth Junction 4
Padova 4
Redwood City 4
Rio de Janeiro 4
Saint Petersburg 4
Vigevano 4
Aversa 3
Bari 3
Bologna 3
Borås 3
Brescia 3
Buenos Aires 3
Changchun 3
Dallas 3
Laives 3
Lanzhou 3
Luxembourg 3
Parma 3
Sacramento 3
Totale 7.158
Salva come PNG Salva come JPEG
Nome #
Anemia in patients with Covid-19: pathogenesis and clinical significance 208
Antigeni minori di istocompatibilità 121
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 94
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 94
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 84
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 84
Spectrum of the mutations in Bernard-Soulier syndrome. 82
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 82
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 81
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 81
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 80
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 79
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 79
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 79
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 78
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 78
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 77
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 77
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 77
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 77
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 76
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 75
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 75
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 75
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 75
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 75
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 74
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 74
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 74
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 74
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 73
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 73
Inherited thrombocytopenias. The evolving spectrum. 73
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 73
Inherited thrombocytopenias in the era of personalized medicine 72
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 72
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 72
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 71
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 70
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 70
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 70
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 69
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 69
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 69
Platelet-independent defect in hemostasis associated with sirolimus use 68
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 67
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 67
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 67
In vitro and in vivo effects of desmopressin on platelet function 67
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 66
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 66
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 66
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 66
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 66
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 65
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 65
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 65
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 65
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 65
Desmopressin and platelets: In vitro and in vivo studies 65
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 65
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 65
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 64
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 64
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 64
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 64
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 64
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 64
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 64
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 64
Platelet count and aging 63
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function 63
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 63
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 63
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 63
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 63
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 63
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 62
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 62
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 62
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 62
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 62
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 62
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 62
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 61
Von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets. 60
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia. 60
Ristocetin-induced platelet agglutination stimulates GPIIb-IIIa-dependent calcium influx. 60
Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation 59
Effetto del Diltiazem sulla funzionalità piastrinica ex vivo 59
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 59
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 59
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 58
ANKRD26-related thrombocytopenia and myeloid malignancies 58
In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? 57
Megakaryocytes derived from patients with the classical form of Bernard-Soulier syndrome show no ability to extend proplatelets in vitro. 57
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 57
Is thiazole orange fluorescence of human platelets directly related to their age? 57
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 57
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 56
Totale 7.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.443
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 0 0 0 0 0 0 76 6
2020/20211.012 101 90 34 85 9 123 8 156 80 152 138 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20251.655 48 230 53 84 52 178 141 201 534 89 45 0
Totale 10.843